Oncology Brothers

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Oncology Brothers
Jan 26, 2025, 16:11 | Insight
Insights from ASCOGI25 by Udhayvir Grewal
The 2025 ASCO Gastrointestinal (GI) Cancers Symposium took place from Thursday, January 23 to Saturday,…
Jan 25, 2025, 10:01 | Insight
Insights from ASCOGI25 by Supriya Peshin
The 2025 ASCO Gastrointestinal (GI) Cancers Symposium is taking place from Thursday, January 23 to…
Jan 14, 2025, 12:49 | Blog
Emil Cohen: Discussing HCC treatment options and strategies with Oncology Brothers
Emil Cohen, Associate Professor at MedStar Georgetown University Hospital, shared a post on LinkedIn: "I…
Jan 13, 2025, 10:18 | Blog
SABCS24 Highlights with Laura Huppert - Oncology Brothers
Oncology Brothers shared a post on X: “SABCS24 Part 1: Highlights with Laura Huppert. INSEMA…
Jan 11, 2025, 15:37 | Insight
Brian Shields: Visualizing Digital Opinion Leader Influence in Medicine
Brian Shields, Founder of KOL Pulse, shared a post on LinkedIn: "Please take a look…
Jan 5, 2025, 16:05 | Blog
How the data from GI25 will reinforce our practice - Oncology Brothers
Oncology Brothers shared a post on X: "Going to GI25? Let’s discuss the current SoC…
Jan 1, 2025, 08:59 | Blog
Oncology Brothers: 6 new drugs in Skin Cancer, Thyroid Cancer, Sarcoma and Glioma by U.S. FDA
Oncology Brothers shared a post on X: "2024 approvals: Summary of 6 new drugs/indications in…
Dec 29, 2024, 10:07 | Blog
Oncology Brothers: 14 new drugs/indications in Lung Cancer by FDA in 2024
Oncology Brothers posted on X: "2024 approvals: Summary of 14 new drugs/indications in Lung Cancer…
Dec 27, 2024, 14:24 | Science
Oncology Brothers: 6 new drugs/indications in GI Malignancies by FDA in 2024
Oncology Brothers posted on X: "2024 approvals: Summary of 6 new drugs/indications in GI Malignancies…
Dec 25, 2024, 21:43 | Blog
Rohit Gosain: Summary of 12 new indications in heme malignancies FDA in 2024
Rohit Gosain, Co-Host of Podcast Oncology Brothers, shared a post on LinkedIn: "2024 approvals: Summary…
Dec 25, 2024, 16:25 | Blog
Rohit Gosain: Summary of 8 new drugs/indications in Breast Cancer and Gynae Oncology by FDA
Rohit Gosain, Co-Host of Podcast Oncology Brothers, shared a post on LinkedIn: "2024 approvals: Summary of…
Dec 23, 2024, 14:07 | Blog
Rahul Gosain: Toxicity Check on Chimeric Antigen Receptor T-Cell Therapy
Rahul Gosain, Director of Regional Infusion Services and Medical Director at Wilmot Cancer Institute, shared…
Dec 22, 2024, 05:59 | Insight
How the new data from ASCO GI 25 will change our practice - Oncology Brothers
Oncology Brothers shared a post on X: “In 5 weeks it’s GI25. Let’s discuss the…
Dec 21, 2024, 08:48 | Science
Oncology Brothers: Another ALK inhibitor gets FDA approval
Oncology Brothers posted on X: "Another ALK inhibitor (ensartinib) gets FDA approval eXalt3 study: 1L,…
Dec 16, 2024, 17:51 | Insight
Best of 2024 SABCS - San Antonio Breast Cancer Symposium
The SABCS 2024 (San Antonio Breast Cancer Symposium) took place from December 10th to 13th,…
Dec 13, 2024, 22:22 | Blog
SABCS24 Day 3 Highlights from Oncology Brothers
Oncology Brothers shared a post on X: "SABCS24 Day 3 Highlights  1. EUROPA: ET vs…
Dec 13, 2024, 12:36 | Insight
Jasmin Hundal: Day 2 at the San Antonio Breast Cancer Symposium was packed with insights
Jasmin Hundal, Hematology Oncology Fellow at Cleveland Clinic, shared a post on LinkedIn: “Day 2…
Dec 12, 2024, 14:12 | Blog
SABCS24 Day 2 Highlights from Oncology Brothers
Oncology Brothers posted on X: "SABCS24 Day 2 Highlights 1. EMBER3: Oral SERD in HR+…
Dec 11, 2024, 17:38 | Blog
SABCS24 Day 1 Highlights by Oncology Brothers
Oncology Brothers shared a post on X: "SABCS24 Day 1 Highlights CommunityOnc: FDA Oncology Reviews recent…
Dec 9, 2024, 18:44 | Blog
Supriya Peshin: An extraordinary event hosted by Oncology Brothers
Supriya Peshin, Internal Medicine Resident at Ballad Health, shared a post on X: "What an…
Dec 8, 2024, 05:58 | Blog
Advancements in Oncology by Oncology Brothers at ASH24
Oncology Brothers shared on X: "At ASH24? Look forward to seeing you tomorrow to discuss…
Dec 3, 2024, 18:34 | Insight
Toxicity check for commonly used ADCs with Erika Hamilton and Tian Zhang
Oncology Brothers shared a post on X: “Approval is just a start, managing AEs for…
Dec 1, 2024, 17:36 | Blog
List of key Abstracts from Community Oncologists perspective at SABCS24 - Oncology Brothers
Oncology Brothers shared a post on X: "< 2 weeks to SABCS24, here is a list…
Nov 30, 2024, 17:26 | Blog
Rahul Gosain: Hepatocellular Cancer series - Unresectable HCC with Rachna Shroff
Rahul Gosain, Director of Regional Infusion Services and Medical Director at Wilmot Cancer Institute, shared…
Nov 28, 2024, 18:17 | Blog
SABCS's Social Media Ambassadors 2024
The SABCS 2024 (San Antonio Breast Cancer Symposium) will feature a group of Social Media…
Nov 27, 2024, 12:40 | Blog
Oncology Brothers: Key abstracts from Community Oncologists perspective
Oncology Brothers shared on X: "Less than 2 weeks to SABCS24, here is a list of key…
Nov 26, 2024, 11:36 | Blog
Rohit Gosain: How the data from SABCS24 will change the clinical practice
Rohit Gosain, Co-Host of Podcast Oncology Brothers, shared a post on LinkedIn: "Less then 3 weeks…
Nov 24, 2024, 04:47 | Blog
Zanidatamab is approved by US FDA based off Herizon BTC01
Oncology Brothers shared a post on X: "Zanidatamab (bispecific antibody against Her2) now US FDA…
Nov 15, 2024, 16:41 | Blog
Rahul Gosain: Current treatment landscape for NET with Pamela Kunz
Rahul Gosain, Director of Regional Infusion Services and Medical Director at Wilmot Cancer Institute, shared…
Nov 10, 2024, 02:39 | Blog
Rahul Gosain: Palliative Care with Janet Abrahm and Ishwaria Subbiah
Rahul Gosain, Director of Regional Infusion Services and Medical Director at Wilmot Cancer Institute, shared a…
Nov 7, 2024, 14:52 | Blog
Narjust Florez: Hear Her campaign Increasing awareness about lung cancer in women
Narjust Florez posted on X: "What are those beautiful lung pins that you have been…
Nov 2, 2024, 19:53 | Blog
Rahul Gosain: The current treatment landscape/algorithm for Ovarian Cancer with Martina Murphy
Rahul Gosain, Co-Host of the Oncology Brothers podcast, shared on LinkedIn: "Gynecological Oncology: with Martina…
Oct 31, 2024, 08:27 | Drugs
FDA grants accelerated approval to asciminib for newly diagnosed CML
On October 29, 2024, the FDA granted accelerated approval for asciminib (Scemblix, Novartis AG)  to…
Oct 23, 2024, 14:21 | Blog
Oncology Brothers: The current treatment landscape/algorithm for AML
Mikkael A. Sekeres, Chief of Division Hematology at Sylvester Comprehensive Cancer Center, shared a post…
Oct 20, 2024, 02:48 | Insight
Oncology Brothers: Insights and Evolving Standards at ASH24
Oncology Brothers posted on X: “Going to ASH24? See you there to discuss the current…
Oct 18, 2024, 16:52 | Blog
Oncology Brothers: Lung Cancer Highlights from ESMO24 with Stephen V Liu
Oncology Brothers posted on X: "Lung Cancer Highlights ESMO24 with Stephen V Liu Updates on:…
Oct 18, 2024, 16:40 | Insight
How data from SABCS24 could transform clinical practices
SignifyMD shared a post on X: “October is Breast Cancer Awareness Month and we're excited…
Oct 17, 2024, 15:52 | Blog
Oncology Brothers: Last 4 weeks in Lung Cancer
Oncology Brothers shared a post on X: "Last 4 weeks in Lung Cancer: 1. PR:…
Oct 17, 2024, 14:28 | Blog
Rahul Gosain: The FDA approval of Axatilimab and latest advancements in GVHD with Shernan Holtan
Rahul Gosain posted on LinkedIn: "Hematology: Here Rohit Gosain and I the FDA approval of Axatilimab…
Oct 14, 2024, 15:14 | Drugs
Toni Choueiri: Talazoparib with or without enzalutamide in mCRPC
Toni Choueiri shared on X: ''JUST IN: HUGE NEWS ==> OS benefit from TALAPRO-2 study…
Oct 13, 2024, 05:49 | Blog
Inavolisib now FDA approved based off INAVO120 - Oncology Brothers
Oncology Brothers shared on X: "Inavolisib now FDA approved based off INAVO120: Ph III, Inavolisib…
Oct 12, 2024, 21:55 | Blog
Nazli Dizman: Supporting our international medical graduates in hematology/oncology
Nazli Dizman, Haemato- Oncologist Fellow at MD Anderson Cancer Center, share her recent article on…
Oct 12, 2024, 11:52 | Blog
Oncology Brothers: GI Malignancy Highlights from ESMO24 with Kristen Ciombor
Oncology Brothers posted on X: "GI Malignancy Highlights from ESMO24 with Kristen Ciombor LEAP012 KN811…
Oct 12, 2024, 10:30 | Insight
FDA Approves Inavolisib with Palbociclib and Fulvestrant for Advanced Breast Cancer
On October 10, 2024, the FDA approved inavolisib (Itovebi, Genentech, Inc.) in combination with palbociclib…
Oct 11, 2024, 19:53 | Blog
Rahul Gosain: GI Malignancy Highlights from ESMO24
Rahul Gosain shared a post about GI Malignancy Highlights. Read his post on LinkedIn below:…
Sep 23, 2024, 09:39 | Blog
Rahul Gosain: Lung Cancer Highlights from WCLC24 with Gilberto Lopes
Rahul Gosain shared on LinkedIn: “Lung Cancer Highlights from WCLC24 with GILBERTO de lima LOPES…
Sep 19, 2024, 14:05 | Blog
Yuksel Urun: The conference rooms are no longer enough for GU sessions at ESMO 24
Petros Grivas shared a post by Yuksel Urun on X: "Thrilled to co-chair GU session…
Sep 14, 2024, 17:15 | Societies
45 Posts not to miss from ESMO24 Day 1
The ESMO Congress 2024 is ongoing in Barcelona, from September 13 to 17, 2024, at…
Sep 14, 2024, 13:37 | Blog
Coral Olazagasti: Many laughs interviewing Charu Aggarwal and Rami Manochakian
Coral Olazagasti shared a post on X: ''So many laughs interviewing Charu Aggarwal and Rami…
Sep 13, 2024, 09:31 | Insight
WCLC24 Highlights by Oncology Brothers
Oncology Brothers shared on X: "WCLC24 Highlights Community Oncology: HARMONi2 in mNSCLC CM77TvsCM816 resectable NSCLC…
Sep 12, 2024, 10:06 | Blog
Rami Manochakian: The latest data in management of stage IV NSCLC at “Advancement in Oncology” event
Rami Manochakian shared a post on X: "The amazing experts Drs Narjust Florez & Jarushka Naidoo…
Sep 11, 2024, 04:28 | Societies
Dr. Coral Olazagasti's highlights from WCLC24 - Part 2
WCLC is a major international event focused on the latest advancements in lung cancer research, treatment,…
Sep 10, 2024, 13:45 | Societies
Rami Manochakian's key highlights from WCLC24
WCLC is a major international event focused on the latest advancements in lung cancer research,…
Sep 10, 2024, 13:18 | Societies
Keeping up with WCLC24 with Eric K. Singhi
The WCLC24 is taking place at the San Diego Convention Center from September 7 to…
Sep 9, 2024, 15:30 | Societies
25 Posts Not To Miss from Day 2 of WCLC24
The International Association for the Study of Lung Cancer (IASLC) is a global, multidisciplinary organization committed…
Sep 9, 2024, 11:35 | Societies
Inside WCLC24 - Recap by Estela Rodriguez
The WCLC24 is taking place at the San Diego Convention Center from September 7 to…
Sep 7, 2024, 11:16 | Drugs
Paolo Tarantino: Recommended read on adjuvant ribociclib in preparation for the ESMO24
Oncology Brothers shared a post by Paolo Tarantino on X, adding: “Adjuvant abemaciclib preferred for…
Sep 1, 2024, 07:58 | Insight
Rahul Gosain: The current SoC/landscape for CML with Jorge Eduardo Cortes
Rahul Gosain shared on LinkedIn: “Hematology: with Jorge Eduardo Cortes we discuss the current SoC/landscape…
Aug 27, 2024, 17:25 | Blog
Eric K. Singhi: Register for the Oncology Brothers Thoracic Oncology Live Event at WCLC24
Eric K. Singhi shared on X: "Still not too late to register for the Oncology…
Aug 25, 2024, 17:04 | Blog
Rahul Gosain: Current SoC/landscape for Follicular and Mantle Cell Lymphoma with Pallawi Torka
Rahul Gosain shared on LinkedIn: “Hematology: with Pallawi Torka we discuss the current SoC/landscape for…
Aug 23, 2024, 14:13 | Insight
Oncology Brothers: Discussions around the algorithm for DLBCL
Oncology Brothers shared on X: "This is the algorithm we have used during our discussion…
Aug 20, 2024, 10:18 | Blog
Key points by Oncology Brothers on Durva+Chemo approval based off AEGEAN trial
H. Jack West, Vice President of Clinical Development at Summit Therapeutics, Inc, shared a post…
Aug 20, 2024, 08:03 | Insight
Oncology Brothers: How the data from WCLC24 will change our clinical practice
Estela Rodriguez shared a post by Oncology Brothers on X, adding: “Excited to share the…
Aug 19, 2024, 10:15 | Blog
Eric Singhi: Can’t-miss Oncology Brothers' LIVE event at WCLC24
Eric Singhi shared a post on X by Oncology Brothers, adding: "Can’t-miss Oncology Brothers' LIVE…
Aug 14, 2024, 13:06 | Blog
Jennifer Marks: Treatment of melanoma from ASCO guidelines
Jennifer Marks, Thoracic Oncologist at Georgetown Lombardi, shared a post on X: “Treatment of melanoma…
Aug 11, 2024, 12:43 | Blog
Oncology Brothers: Melanoma Treatment Algorithm with Allison Betof Warner
Rahul Gosain posted on LinkedIn: "Melanoma: with Allison Betof Warner we the SoC for early, locally…
Aug 6, 2024, 16:58 | Blog
Rahul Gosain: Let’s cure cancer and save hearts with Susan Dent
Rahul Gosain, Director of Regional Infusion Services and Medical Director  at Wilmot Cancer Institute, shared…
Aug 6, 2024, 15:38 | Blog
Oncology Brothers: Lung Series with Isabel Preeshagul
Oncology Brothers posted on X: "Lung Series: with Isabel Preeshagul we spoke the SoC for…
Aug 1, 2024, 13:27 | Blog
Rahul Gosain: How will the data from WCLC24 impacts our day to day clinical practice
Rahul Gosain shared a post on LinkedIn: "WCLC24 ~5 weeks away! Let discuss the current…
Jul 28, 2024, 12:32 | Blog
Isabel Preeshagul: Loved joining Oncology Brothers to discuss frontline treatment for stage IV disease without a driver
Isabel Preeshagul, Thoracic Medical Oncologist at Memorial Soan Kettering Cancer Center, shared a post on…
Jul 22, 2024, 02:04 | Blog
Oncology Brothers: A discussion with Balazs Halmos for mNSCLC with actionable mutations in 1L
Oncology Brothers shared a post on X: "Lung Series: This is the Algorithm we have…
Jul 20, 2024, 17:56 | Blog
Oncology Brothers: Lung Series with Balazs Halmos
Oncology Brothers shared a post on X: "Lung Series: with Balazs Halmos we discussed the SoC for…
Jul 20, 2024, 10:51 | Blog
Toni Choueiri: TiNivo2 results are out
Toni Choueiri shared a post on X: ''TiNivo2 results are out - adding PD1 inhibitor…
Jul 18, 2024, 14:56 | Opinion
Thrilled to see ASCO focusing on Community Oncology - Oncology Brothers
Oncology Brothers shared a post by Robin Zon, on X, adding: "Thrilled to see ASCO…
Jul 11, 2024, 13:02 | Blog
Eric Singhi: Clinical updates for patients with small cell lung cancer
Eric Singhi shared a post by Oncology Brothers on X, adding: "Always a great time…
Jul 10, 2024, 00:57 | Blog
Pre-analytical phase challenges and biomarker testing in lung cancer - Precision Oncology CONNECT
Precision Oncology CONNECT shared a post on X: ''Do you understand the specific biomarkers detected by…
Jul 10, 2024, 00:09 | Insight
Yael Waknine: 21 oncology topics in 1.5 days, with take-home algorithms
Yael Waknine, Medical Director of Oncology Continuing Education and Integrity, shared a post on X:…
Jul 4, 2024, 14:08 | Blog
Oncology Brothers: Starting the morning with Dr. Jason Zittel
Oncology Brothers shared a post on X: "Starting the morning with Drs. Jason Zittel, Renuka…
Jul 4, 2024, 12:07 | Blog
Jordyn Silverstein: Bladder cancer illness script time
Jordyn Silverstein, Hematology/Oncology Fellow at UCLA, made the following post on X: "Illness script time!…
Jul 4, 2024, 03:22 | Blog
Updates from Upstate NY Cancer Symposium by Oncology Brothers
Oncology Brothers shared on X: "Updates from Upstate NY Cancer Symposium: India is now T20 Champions! Back…
Jul 4, 2024, 01:10 | Blog
Matthew Cortese: Great talk by Jens Hillengass on frontline Multiple Myeloma treatment at the Upstate New York Cancer Symposium
Matthew Cortese, Associate Professor at Roswell Park, shared on X: "Great talk by our Myeloma…
Jul 3, 2024, 17:15 | Insight
Breast Cancer takeaways by Arya Roy from Upstate NY Cancer Symposium
Oncology Brothers shared on X: "Breast Cancer takeaways by Arya Roy from Upstate NY Cancer…
Jul 3, 2024, 08:59 | Blog
Can’t wait for the inaugral Integrity CE, Wilmot Cancer Institute, Roswell Park, Upstate NY Cancer Symposium - Oncology Brothers
Oncology Brothers shared a post on X: “Can’t wait for the inaugral Integrity CE, Wilmot…
Jul 3, 2024, 01:51 | Blog
Oncology Brothers: Stephen V Liu covering NSCLC where treatment is with curative intent
Oncology Brothers shared on X: "Stephen V Liu from Georgetown Lombardi covering NSCLC where treatment is…
Jun 28, 2024, 14:13 | Blog
Mark Lewis: Few people make this only child feel more included than Oncology Brothers
Mark Lewis shared a post by Oncology Brothers on X, adding the following: "Few people…
Jun 27, 2024, 14:30 | Blog
2024 Upstate Cancer Symposium
Yael Waknine, Medical Director of Oncology Continuing Education and Integrity, shared a post on LinkedIn: …
Jun 24, 2024, 07:29 | Blog
Rahul Gosain: GU Malignancy Highlights from ASCO24 with Toni Choueiri
Rahul Gosain shared a post on LinkedIn: "GU (Genitourinary) Malignancy Highlights from ASCO24 (American Society…
Jun 10, 2024, 15:27 | Blog
Cathy Eng: Join us on 6/22/2024 for ASCO24 post meeting update
Cathy Eng shared on X/Twitter: "Please join us in at Nashville 6/22/2024! For those that didn't…
Jun 6, 2024, 23:45 | Blog
M. Talha Ugurlu: I attended the Advancements in Oncology event by Oncology Brothers
M. Talha Ugurlu, Internal Medicine resident at Tufts School of Medicine, shared a post on X:…
Jun 4, 2024, 09:39 | Societies
ASCO24 Day 4 Highlights by The Oncology Brothers
The Oncology Brothers shared on X: "ASCO24 Day 4 Highlights: 1. ICTAN: Adjuvant anti-EGFR duration…
Jun 4, 2024, 03:08 | Societies
ASCO24 Day 3 Highlights by The Oncology Brothers
The Oncology Brothers shared on X: "1. DB06 TDxD HR+ metastatic breast cancer (mBC) 2.…
Jun 1, 2024, 12:55 | Societies
Day 1 ASCO24 Highlights by Oncology Brothers
Oncology Brothers shared on X: Day 1 ASCO24 Highlights: 1. CROWN: Lorlatinib in ALK mNSCLC…
May 30, 2024, 10:57 | Blog
Eric K. Singhi: Come join us at the ASCO Trainee and Early Career Lounge
Eric K. Singhi, Assistant Professor at MD Anderson Cancer Center, shared a post on X:…
May 28, 2024, 07:41 | Blog
Margaret Gatti-Mays: How presented data at ASCO24 will impact clinical care in oncology clinics
Margaret Gatti-Mays, Co-Director of the Division of Medical Oncology at the Ohio State University, shared a…
May 25, 2024, 11:59 | Blog
Vivek Subbiah: ASCO 24 time to learn the latest and greatest in Tissue Agnostic Precision Medicine
Vivek Subbiah shared on X: “It's ASCO 24 time Mark your calendars to learn the latest…
May 22, 2024, 14:07 | Blog
How the data from ASCO24 is going to change our practice - Oncology Brothers
Oncology Brothers shared on X: "Let's talk how the data from ASCO24 is going to…
May 22, 2024, 03:21 | Insight
Rahul Gosain: HemeSeries, with Naveen Pemmaraju we discuss treatment options and current landscape of Myelofibrosis
Rahul Gosain, Director of Regional Infusion Services at Wilmot Cancer Institute, shared on LinkedIn: “HemeSeries: with Naveen…
May 15, 2024, 14:51 | Blog
Rahul Gosain: HemeSeries with Samer Al Hadidi for Relapsed/Refractory Multiple Myeloma
Rahul Gosain, Director of Regional Infusion Services at Wilmot Cancer Institute, shared on LinkedIn: "HemeSeries: with Samer…
May 12, 2024, 07:53 | Insight
Rahul Gosain: Multidisciplinary approach in treating GISM HCC
Rahul Gosain, Director of Regional Infusion Services at Wilmot Cancer Institute, shared a post on LinkedIn: “GI…
May 6, 2024, 08:18 | Blog
Margaret Gatti-Mays: Excited to be part of this amazing program
Margaret Gatti-Mays, Co-Director of The Ohio State Uiversity Division of Medical Oncology, shared a post by…
12
All: 122 Posts: 1 - 100
Special Coverage